Fabio Pellegrini Selected Research

Obesity

8/2012	Epicardial adipose tissue and idiopathic deep venous thrombosis: an association study.
12/2011	The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.
8/2011	Educational inequalities in obesity, abdominal obesity, and metabolic syndrome in seven Latin American cities: the CARMELA Study.
4/2011	Effect of obesity, serum lipoproteins, and apolipoprotein E genotypes on mortality in hospitalized elderly patients.
1/2008	CARMELA: assessment of cardiovascular risk in seven Latin American cities.
2/2005	The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabio Pellegrini Research Topics

Disease

14	Neoplasms (Cancer) 09/2014 - 09/2006
13	Multiple Sclerosis 01/2024 - 12/2006
13	Type 2 Diabetes Mellitus (MODY) 01/2015 - 12/2003
11	Chronic Renal Insufficiency 10/2016 - 03/2008
9	Myocardial Infarction 01/2017 - 06/2008
8	Relapsing-Remitting Multiple Sclerosis 01/2023 - 04/2007
7	Hemorrhage 02/2013 - 07/2007
6	Chronic Kidney Failure (Chronic Renal Failure) 12/2018 - 07/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 12/2003
6	Obesity 08/2012 - 02/2005
5	Stroke (Strokes) 01/2017 - 07/2010
5	Thrombosis (Thrombus) 02/2013 - 12/2003
5	Lung Neoplasms (Lung Cancer) 01/2013 - 02/2011
5	Insulin Resistance 01/2013 - 06/2003
5	Hypertension (High Blood Pressure) 08/2012 - 01/2008
3	Disease Progression 07/2022 - 04/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 02/2016 - 01/2014
3	Overweight 01/2014 - 12/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 12/2007
3	Breast Neoplasms (Breast Cancer) 01/2013 - 12/2005
2	Albuminuria 12/2018 - 12/2009
2	Inflammation (Inflammations) 02/2016 - 02/2013
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2015 - 09/2007
2	Dyspnea (Shortness of Breath) 01/2014 - 10/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 10/2011
2	Nausea 01/2014 - 01/2013
2	Vomiting 01/2014 - 01/2013
2	Hypocalcemia 01/2013 - 11/2012
2	Dyslipidemias (Dyslipidemia) 08/2012 - 04/2011
2	Hemophilia A (Haemophilia) 07/2012 - 07/2012
2	Dementia (Dementias) 07/2012 - 10/2011
2	Body Weight (Weight, Body) 06/2010 - 01/2010
2	Diabetes Complications 12/2009 - 11/2005
2	Proteinuria 04/2009 - 03/2008
2	Erectile Dysfunction 01/2007 - 04/2003
1	Periodontitis 05/2017
1	Anemia 01/2017
1	Progressive Multifocal Leukoencephalopathy 04/2016
1	Stomatognathic Diseases (Dental Disease) 10/2015
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2015
1	Stillbirth 01/2015
1	Adenocarcinoma 09/2014

Drug/Important Bio-Agent (IBA)

9	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 06/2003
9	Insulin (Novolin)FDA Link 01/2014 - 04/2003
7	Dimethyl FumarateIBA 01/2024 - 12/2018
7	Natalizumab (Tysabri)FDA Link 01/2024 - 11/2014
6	Messenger RNA (mRNA)IBA 09/2014 - 08/2011
6	CholesterolIBA 08/2012 - 01/2005
4	teriflunomideIBA 01/2024 - 12/2018
4	Glatiramer Acetate (Copaxone)FDA Link 01/2023 - 04/2016
4	Biomarkers (Surrogate Marker)IBA 12/2013 - 04/2009
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2013 - 05/2007
4	Parathyroid Hormone (Parathormone)IBA 01/2013 - 03/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 03/2008
4	Hemoglobins (Hemoglobin)IBA 08/2012 - 01/2007
4	LipidsIBA 04/2011 - 01/2005
3	HematinicsIBA 01/2017 - 07/2010
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2016 - 02/2010
3	MicroRNAs (MicroRNA)IBA 02/2016 - 01/2012
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013 - 03/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2012 - 12/2003
3	Apolipoproteins E (ApoE)IBA 10/2011 - 04/2011
2	Fingolimod Hydrochloride (FTY720)FDA Link 07/2022 - 12/2018
2	InterferonsIBA 12/2018 - 04/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2018 - 12/2009
2	CreatinineIBA 12/2018 - 04/2009
2	ResistinIBA 01/2015 - 01/2014
2	insulin receptor-related receptor (IRR)IBA 01/2015 - 06/2012
2	Antihypertensive Agents (Antihypertensives)IBA 01/2014 - 03/2012
2	Metformin (Glucophage)FDA LinkGeneric 02/2013 - 01/2013
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2013 - 12/2011
2	CalciumIBA 11/2012 - 03/2011
2	LDL CholesterolIBA 08/2012 - 03/2008
2	recombinant FVIIa (rFVIIa)FDA Link 07/2012 - 07/2007
2	AutoantibodiesIBA 07/2012 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 08/2011 - 12/2009
2	ApolipoproteinsIBA 05/2011 - 04/2011
2	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2011 - 06/2010
2	Hormones (Hormone)IBA 02/2010 - 12/2007
2	Transcription Factors (Transcription Factor)IBA 02/2010 - 12/2007
2	Blood Glucose (Blood Sugar)IBA 01/2010 - 05/2005
2	PPAR gammaIBA 12/2007 - 05/2007
2	AntioxidantsIBA 09/2007 - 12/2003
2	Interferon-betaIBA 04/2007 - 12/2006
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2024
1	PlacebosIBA 01/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2018
1	Angiotensin Receptor AntagonistsIBA 12/2018
1	ChemokinesIBA 02/2016
1	DisintegrinsIBA 04/2015
1	Peptide Hydrolases (Proteases)FDA Link 04/2015
1	multidrug resistance-associated protein 1IBA 09/2014
1	NucleosidesIBA 09/2014
1	Gemcitabine FDA Link 09/2014

Therapy/Procedure

19	Therapeutics 01/2023 - 07/2007
7	Renal Dialysis (Hemodialysis) 05/2017 - 03/2012
3	Precision Medicine 07/2023 - 01/2020
3	Terminal Care (Care, Terminal) 01/2014 - 01/2011
3	Activities of Daily Living (ADL) 07/2012 - 01/2010
1	Tracheostomy 03/2015